Hosted by the ASPET Mid-Atlantic Pharmacology Society
Wednesday, March 16, 2022, 12:00 pm – 1:00 pm ET
Biotechnology is a science-driven industry with increasingly positive impact on problems related to public health. The roundtable will be a stage for presenting and promoting biotechnology to the ASPET community, with the goal of raising awareness among
academicians, students, and other public and private scientific interests of potential opportunities to get involved with the cutting-edge innovation of the exciting world of biotechnology. Panelists will present and discuss novel technology platforms
and approaches to solving problems related to public health, followed by ample Q&A with the audience.
Moderator
R. Kyle Palmer, PhD, Co-Founder and Chief Science Officer of Opertech Bio, Inc., Vice-President Mid-Atlantic Pharmacology Society
Speakers
Rui Jing Jiang, Co-Founder, and CEO, Avisi Technologies
VisiPlate: A Nanotech Defense Against Blindness from Glaucoma
Ross Corriden, PhD, Associate Director, Neuron23
Navigating the Transition between Academia, Pharma and Biotech
Mark Rampy, PhD, Founder & CEO, Tailored Therapeutics
Future Directions for Adoptive Cell Therapy in Cancer